Dechra Pharmaceuticals Share Price (DPH)

2,667.00 +3.00 (+0.11%) delayed: 8:28AM GMT
Bid price 2,664.00 Open price 2,666.00
Ask price 2,670.00 Prev close 2,664.00
High price 2,682.00 Spread 0.22%
Low price 2,658.00 Volume 16,581

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international specialist veterinary pharmaceuticals and relates products business. Its expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 2,667.00 Net Gearing (%) 42.98
Market Capitalisation (£m) 2,726.82 Gross Gearing (%) 52.57
Shares in issue (m) 102.36 Debt Ratio 47.06
P/E Ratio 94.84 Debt-to-Equity Ratio 0.80
Total dividends per share (p) 21.44 Assets / Equity Ratio 2.11
Dividend Yield (%) 0.85 Price to book value 9.01
Dividend cover (x) 1.24 ROCE (%) 5.00
Earning per share (p) 28.09 EPS Growth (%) 100.64
52 week high / low 2,720.00 / 1,622.00 DPS Growth (%) 16.14

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
05/03/2018 EXR Ian Page CEO 1,465
26/02/2018 EXR Richard Cotton D 21,033
20/09/2017 SEXR Ian Page CEO 54,910
20/09/2017 SEXR Tony Griffin ED 29,937
19/09/2017 EXR Ian Page CEO 115,334

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

10:46 15/03/2018

Additional Listing

RNS Number : 8491H Dechra Pharmaceuticals PLC 15 March 2018           15 March 2018   Dechra® Pharmaceuticals PLC (Dechra or the Company)      Additional Listing     An application has been made to the Financial Conduct Authority...

07:00 15/03/2018

Block listing six monthly return

RNS Number : 7543H Dechra Pharmaceuticals PLC 15 March 2018   BLOCK LISTING SIX MONTHLY RETURN   Information provided on this form must be typed or printed electronically and provided to an ris .   Date: 15 March 2018   Name of applicant : Dechra...

12:30 05/03/2018

Director Deals - Dechra Pharmaceuticals PLC (DPH)

Ian Page, Chief Executive Officer, exercised 1,465 shares in the company on the 2nd March 2018 at a price of 614.00p. The Director now holds 738,697 shares. Story provided by Director deals data provided by

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p and...

Register now for FREE Dechra Pharmaceuticals share price discussions